Aspire Biopharma Holdings, Inc. — All Filings
192 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
10-Q/A
25-NSE
3
4
4/A
424B3
424B4
425
8-A12B
8-K
8-K/A
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-K
NT 10-Q
PRE 14A
RW
S-1
S-1/A
S-4
S-4/A
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0001493152-26-007883 | Feb 24, 2026 | — |
| S-1 | S-1 | 0001493152-26-007123 | Feb 17, 2026 | — |
| PRE 14A | PRE 14A | 0001493152-26-006485 | Feb 12, 2026 | — |
| SCHEDULE 13G | — | 0001213900-26-015382 | Feb 12, 2026 | — |
| 8-K | 8-K | 0001493152-26-006343 | Feb 12, 2026 | Feb 6, 2026 |
| 8-K | 8-K | 0001493152-26-005640 | Feb 6, 2026 | Feb 2, 2026 |
| 8-K | 8-K | 0001493152-26-004543 | Jan 30, 2026 | Jan 26, 2026 |
| 8-K | 8-K | 0001493152-26-002326 | Jan 15, 2026 | Jan 8, 2026 |
| 8-K | 8-K | 0001493152-26-002057 | Jan 13, 2026 | Jan 7, 2026 |
| 8-K | 8-K | 0001493152-26-000518 | Jan 6, 2026 | Jan 1, 2026 |
| EFFECT | — | 9999999995-25-003714 | Dec 12, 2025 | — |
| S-1 | S-1 | 0001493152-25-025819 | Dec 3, 2025 | — |
| 10-Q/A | 10-Q/A | 0001493152-25-023619 | Nov 14, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0001493152-25-022595 | Nov 14, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001493152-25-022580 | Nov 14, 2025 | Nov 11, 2025 |
| 8-K | 8-K | 0001493152-25-020891 | Nov 5, 2025 | Nov 4, 2025 |
| 8-K | 8-K | 0001493152-25-018512 | Oct 17, 2025 | Oct 15, 2025 |
| EFFECT | — | 9999999995-25-003148 | Sep 29, 2025 | — |
| CORRESP | — | 0001493152-25-015781 | Sep 26, 2025 | — |
| S-1/A | S-1/A | 0001493152-25-015778 | Sep 26, 2025 | — |
| 8-K | 8-K | 0001493152-25-015773 | Sep 26, 2025 | Sep 22, 2025 |
| UPLOAD | — | 0000000000-25-010426 | Sep 24, 2025 | — |
| DEF 14A | DEF 14A | 0001493152-25-014523 | Sep 23, 2025 | Sep 22, 2025 |
| S-1 | S-1 | 0001493152-25-014085 | Sep 18, 2025 | — |
| PRE 14A | PRE 14A | 0001641172-25-026871 | Sep 8, 2025 | — |
| 8-K | 8-K | 0001641172-25-025257 | Aug 22, 2025 | Aug 19, 2025 |
| 10-Q | 10-Q | 0001641172-25-023573 | Aug 13, 2025 | Jun 30, 2025 |
| 10-Q/A | 10-Q/A | 0001641172-25-023566 | Aug 13, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001641172-25-021595 | Jul 30, 2025 | Jul 24, 2025 |
| 8-K | 8-K | 0001641172-25-015653 | Jun 18, 2025 | Jun 17, 2025 |
| 4/A | — | 0001641172-25-014569 | Jun 10, 2025 | Jun 4, 2025 |
| 8-K | 8-K | 0001641172-25-014445 | Jun 10, 2025 | — |
| 4 | — | 0001641172-25-014102 | Jun 6, 2025 | Jun 4, 2025 |
| EFFECT | — | 9999999995-25-001770 | May 29, 2025 | — |
| CORRESP | — | 0001641172-25-012627 | May 28, 2025 | — |
| UPLOAD | — | 0000000000-25-005403 | May 20, 2025 | — |
| SCHEDULE 13G/A | — | 0001641172-25-011555 | May 19, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-072232 | May 15, 2025 | — |
| 10-Q | 10-Q | 0001641172-25-010316 | May 14, 2025 | Mar 31, 2025 |
| S-1 | S-1 | 0001641172-25-010013 | May 13, 2025 | — |
| SCHEDULE 13G/A | — | 0001641172-25-009072 | May 7, 2025 | — |
| 8-K | 8-K | 0001641172-25-007852 | Apr 30, 2025 | Apr 24, 2025 |
| SCHEDULE 13G/A | — | 0001641172-25-005902 | Apr 23, 2025 | — |
| EFFECT | — | 9999999995-25-001165 | Apr 21, 2025 | — |
| CORRESP | — | 0001641172-25-005445 | Apr 18, 2025 | — |
| 8-K | — | 0001641172-25-005427 | Apr 18, 2025 | — |
| SCHEDULE 13G/A | — | 0001641172-25-005239 | Apr 17, 2025 | — |
| UPLOAD | — | 0000000000-25-004018 | Apr 16, 2025 | — |
| SCHEDULE 13G/A | — | 0001641172-25-003869 | Apr 11, 2025 | — |
| S-1 | — | 0001641172-25-003291 | Apr 9, 2025 | — |